JP2002526409A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526409A5
JP2002526409A5 JP2000573361A JP2000573361A JP2002526409A5 JP 2002526409 A5 JP2002526409 A5 JP 2002526409A5 JP 2000573361 A JP2000573361 A JP 2000573361A JP 2000573361 A JP2000573361 A JP 2000573361A JP 2002526409 A5 JP2002526409 A5 JP 2002526409A5
Authority
JP
Japan
Prior art keywords
lower alkyl
alkyl group
composition according
formula
degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000573361A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002526409A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP1999/005321 external-priority patent/WO2000020002A1/en
Publication of JP2002526409A publication Critical patent/JP2002526409A/ja
Publication of JP2002526409A5 publication Critical patent/JP2002526409A5/ja
Withdrawn legal-status Critical Current

Links

JP2000573361A 1998-10-02 1999-09-29 光障害性網膜変性疾患処置用組成物 Withdrawn JP2002526409A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10297298P 1998-10-02 1998-10-02
US60/102,972 1998-10-02
US11070098P 1998-12-03 1998-12-03
US60/110,700 1998-12-03
PCT/JP1999/005321 WO2000020002A1 (en) 1998-10-02 1999-09-29 Composition for treatment of light-injured retinal degeneration disease

Publications (2)

Publication Number Publication Date
JP2002526409A JP2002526409A (ja) 2002-08-20
JP2002526409A5 true JP2002526409A5 (https=) 2006-11-24

Family

ID=26799937

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000573361A Withdrawn JP2002526409A (ja) 1998-10-02 1999-09-29 光障害性網膜変性疾患処置用組成物

Country Status (8)

Country Link
US (1) US6248759B1 (https=)
EP (1) EP1117404A1 (https=)
JP (1) JP2002526409A (https=)
AR (1) AR020681A1 (https=)
AU (1) AU5998399A (https=)
BR (1) BR9914254A (https=)
CA (1) CA2346086A1 (https=)
WO (1) WO2000020002A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005204391A1 (en) * 2004-01-14 2005-07-28 Lavipharm Laboratories, Inc. Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
WO1990006123A1 (en) * 1988-12-05 1990-06-14 Houston Biotechnology Incorporated Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction
FR2642307A1 (fr) * 1989-01-27 1990-08-03 Corbiere Jerome Medicament pour le traitement des maladies degeneratives de la retine et notamment des maladies conditionnees genetiquement, et un procede pour leur obtention
JP3041923B2 (ja) * 1990-06-27 2000-05-15 藤沢薬品工業株式会社 ジヒドロピリジン化合物を含有する抗炎症および活性酸素産生抑制剤
US5691360A (en) * 1993-12-08 1997-11-25 Alcon Laboratories, Inc. Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
EP0911027A4 (en) 1996-04-26 2000-11-29 Fujisawa Pharmaceutical Co THE DIHYDROPYRIDINE CONTAINS TO IMPROVE THE CIRCULATION OF THE EYE-SURROUNDING TISSUE
JPH1072347A (ja) 1996-05-27 1998-03-17 Otsuka Pharmaceut Co Ltd 眼血管血流改善剤

Similar Documents

Publication Publication Date Title
JP2006507220A5 (https=)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
RU2011103741A (ru) Композиции и способы лечения заболевания сетчатки
JP2022081661A5 (https=)
JP2007522098A5 (https=)
WO2005056524A3 (en) Therapeutic agents useful for treating pain
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
JP2013540114A5 (https=)
JP2006524222A5 (https=)
JP2008514732A5 (https=)
JP2005530811A5 (https=)
JP2004516314A5 (https=)
JP2006514626A5 (https=)
RU2003114752A (ru) Лечение желудочно-кишечных стромальных опухолей
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
JP2007507494A5 (https=)
JP2002518502A5 (https=)
JP2005508337A5 (https=)
HK1046405A1 (zh) 作为nmda受体拮抗剂用於治疗疼痛的取代的1,5-二氢吡咯-2-酮衍生物
JP2002525323A5 (https=)
DE60322680D1 (de) Opioid-rezeptor-aktive 4-(3-hydroxyphenyl) oder 4-(3-alkoxyphenyl)-1,2,4-triazol-verbindungen
RU2001135802A (ru) Антагонисты рецептора брадикинина
JP2010514733A5 (https=)
JP2005527521A5 (https=)
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen